Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002552:Cerebral Ventricles; D002852:Chromatography, Ion Exchange; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism; D007267:Injections; D007980:Levodopa / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D011437:Propylamines; D051381:Rats; D013047:Specific Pathogen-Free Organisms; D013050:Spectrometry, Fluorescence; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D000928:Antidepressive Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D003986:Dibenzocycloheptenes; D011437:Propylamines; D014316:Tritium; D014443:Tyrosine; D007980:Levodopa; D001545:Benserazide; D009638:Norepinephrine; D006719:Homovanillic Acid